Literature DB >> 31179294

Mild gait impairment in long-term treated patients with neurological Wilson's disease.

Osman Tezayak1, Dietmar Rosenthal1, Harald Hefter1.   

Abstract

BACKGROUND: Abnormal gait is a frequently observed initial symptom of Wilson's disease (WD), which responds well to therapy, but has not been analyzed quantitatively so far. The question therefore is whether abnormalities can be detected by simple quantitative gait measurements in long-term treated Wilson-patients and whether these have a relation to clinical and laboratory findings.
METHODS: In 30 long-term treated Wilson-patients, walking without aid at the preferred gait speed over a distance of 40 meters was analyzed. An Infotronic® gait analysis system which consists of soft tissue shoes with two solid, but flexible plates each containing 8 force transducers was used to record the vertical component of the ground forces and the temporal patterns of foot ground contact. Gait parameters were correlated with clinical scores as well as laboratory findings. Results of Wilson-patients were compared to those of an age- and sex-matched control group.
RESULTS: Wilson-patients walked significantly (P<0.001) slower than normal subjects with equal step length, but lower cadence (P<0.001). Gait speed was negatively correlated with severity of neurological symptoms (r=-0.547; P<0.001) and positively with copper concentration in the 24 h urine (r=0.415; P<0.003). A negative correlation was also found between serum levels of liver enzymes and cadence (r=-0.515; P<0.001). Time normalized temporal patterns of walking were normal.
CONCLUSIONS: The temporal pattern of gait is normal in WD. A compliance dependent reduction of gait speed and cadence underline the necessity of careful long-term therapy monitoring in WD.

Entities:  

Keywords:  Wilson’s disease (WD); abnormal gait; central pattern generators of walking; optimization of therapy; reduction of gait speed

Year:  2019        PMID: 31179294      PMCID: PMC6531653          DOI: 10.21037/atm.2019.04.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  24 in total

Review 1.  Neuropsychological characterization of hepatic encephalopathy.

Authors:  K Weissenborn; J C Ennen; H Schomerus; N Rückert; H Hecker
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

2.  Portal-systemic encephalopathy; neurological complications of liver disease.

Authors:  S SHERLOCK; W H SUMMERSKILL; L P WHITE; E A PHEAR
Journal:  Lancet       Date:  1954-09-04       Impact factor: 79.321

3.  The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration.

Authors:  J N CUMINGS
Journal:  Brain       Date:  1948-12       Impact factor: 13.501

4.  Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.

Authors:  T Kuwert; H Hefter; D Scholz; M Milz; P Weiss; G Arendt; H Herzog; M Loken; M Hennerici; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1992

5.  Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders.

Authors:  Valentina Medici; Vincenzo G Mirante; Luigi R Fassati; Maurizio Pompili; Domenico Forti; Massimo Del Gaudio; Carlo P Trevisan; Umberto Cillo; Giacomo C Sturniolo; Stefano Fagiuoli
Journal:  Liver Transpl       Date:  2005-09       Impact factor: 5.799

6.  Neurological manifestations in Wilson's disease: Report of 119 cases.

Authors:  Alexandre Machado; Hsin Fen Chien; Marta Mitiko Deguti; Eduardo Cançado; Raymundo Soares Azevedo; Milberto Scaff; Egberto Reis Barbosa
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

7.  Neural control of locomotion; The central pattern generator from cats to humans.

Authors: 
Journal:  Gait Posture       Date:  1998-03-01       Impact factor: 2.840

Review 8.  The special nature of human walking and its neural control.

Authors:  Charles Capaday
Journal:  Trends Neurosci       Date:  2002-07       Impact factor: 13.837

9.  Gait asymmetry in community-ambulating stroke survivors.

Authors:  Kara K Patterson; Iwona Parafianowicz; Cynthia J Danells; Valerie Closson; Mary C Verrier; W Richard Staines; Sandra E Black; William E McIlroy
Journal:  Arch Phys Med Rehabil       Date:  2008-02       Impact factor: 3.966

10.  Expressing gait-line symmetry in able-bodied gait.

Authors:  Piotr Jeleń; Andrzej Wit; Krzysztof Dudziński; Lee Nolan
Journal:  Dyn Med       Date:  2008-12-19
View more
  3 in total

1.  Analysis of Single-Leg Hopping in Long-Term Treated Patients with Neurological Wilson's Disease: A Controlled Pilot Study.

Authors:  Harald Hefter; Sara Samadzadeh; Dietmar Rosenthal; Osman Tezayak
Journal:  Medicina (Kaunas)       Date:  2022-02-07       Impact factor: 2.430

2.  Mildly Impaired Foot Control in Long-Term Treated Patients with Wilson's Disease.

Authors:  Sara Samadzadeh; Harald Hefter; Osman Tezayak; Dietmar Rosenthal
Journal:  J Funct Morphol Kinesiol       Date:  2021-12-31

3.  Analysis of Running in Wilson's Disease.

Authors:  Sara Samadzadeh; Harald Hefter; Osman Tezayak; Dietmar Rosenthal
Journal:  Sports (Basel)       Date:  2022-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.